Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Trial of Rifaximin and Norfloxacin in Primary and Secondary Prophylaxis of Spontaneous Bacterial Peritonitis(SBP) in Cirrhotic Patients

NCT03695705 is registered in ClinicalTrials.gov with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor.

NCT NCT03695705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03695705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Trial of Rifaximin and Norfloxacin in Primary and Secondary Prophylaxis of Spontaneous Bacterial Peritonitis(SBP) in Cirrhotic Patients
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2016
Completion date
June 30, 2017
Enrollment
142 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver